Tirzepatide (LY3298176) is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed for type 2 diabetes research. This compound demonstrates superior efficacy in glucose control and weight management compared to selective GLP-1 receptor agonists.
Our pharmaceutical-grade Tirzepatide is produced under strict quality controls, offering researchers a reliable compound for metabolic studies. The white powder formulation maintains excellent stability when stored properly.
For researchers wondering where to buy Tirzepatide, our facility provides bulk quantities with consistent quality. The compound shows particular promise in diabetes treatment research due to its unique dual agonist mechanism.
Key advantages of our Tirzepatide include high purity (>98%), reliable batch-to-batch consistency, and comprehensive analytical documentation. The product is supplied for research purposes only.
Tirzepatide's molecular structure (C225H348N48O68) enables its dual receptor activity, with greater affinity for GIP receptors than GLP-1 receptors. This pharmacological profile makes it an important compound for studying metabolic pathways.
When considering where to buy Tirzepatide for your research needs, our manufacturing capabilities ensure a stable supply of this promising compound. We offer customization options for specific research requirements.